PRPH ProPhase Labs, Inc. Expected net earnings per share growth this year

PRPH (ProPhase Labs, Inc.) - company brandmark

The resilience of ProPhase Labs, Inc. (PRPH) is based on scaling genetic research and expanding its laboratory network. The annual net income per share trend confirms this trajectory, where 0.00 determines this parameter level. The company is implementing digital home diagnostic systems, yet it faces declining demand for PCR tests and a liquidity shortage.

ProPhase Labs Inc - PRPH Earnings per share growth in current year (period 07/04/2022 - 01/10/2026)

Analytical breakdowns and data insights for company ProPhase Labs, Inc. (PRPH)

- current quotes and average value forecast:
Market Chart ProPhase Labs Inc|PRPH - Price Target Chart
- market capitalization data:
Market Capitalization ProPhase Labs Corp|PRPH - Total Company Value
- shareholders' equity book value data:
Share Book Value ProPhase Labs|PRPH - Company Book Value|Market Value to Book Value prophaselabs.com|PRPH - Aggregate Company Assets
- debt and liquidity details:
Debt to Capital ProPhase Labs, Inc.|PRPH - Long-Term Debt to Equity|Current Liabilities to Equity prophaselabs.com|PRPH - Company Aggregate Debts|Debt to Net Assets Ratio ProPhase Labs Corp|PRPH - Company Long-Term Debts|Company Short-Term Debts ProPhase Labs|Interim Coverage Ratio prophaselabs.com
- financial results and valuation multiples details:
PRPH - Net Profit|Expected Net Profit ProPhase Labs, Inc.|PRPH - Price to Earnings Ratio|Future Price to Earnings Multiple ProPhase Labs Corp|PRPH - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ProPhase Labs Corp|PRPH - Operating profit EBITDA|Net earnings per share (EPS TTM) ProPhase Labs|PRPH - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months prophaselabs.com|PRPH - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year ProPhase Labs, Inc.
Fundamental valuation:ProPhase Labs Inc (PRPH)
Signature product of ProPhase Labs Corp

Assessing the financial stability of ProPhase Labs, Inc. (PRPH) requires an analysis of net profit dynamics. This metric measures the percentage change in earnings per share relative to the same period last year. The annual earnings per share growth indicator allows for the identification of critical trend reversal points and the risk of institutional capital outflow. For ProPhase Labs, Inc. (PRPH), such a metric reflects the synergy efficiency between laboratory diagnostics and the dietary supplement market. The stability of this ratio confirms the viability of the issuer's diversified business model.

Direct competitors

A - Expected net earnings per share growth this year|Earnings per share growth in current year Quest|Illumina Platform (ILMN) - Expected net earnings per share growth this year|Earnings per share growth in current year Exact Sciences (EXAS)|RVTY: Earnings per share trend in current year|Earnings per share growth in current year Bio-Rad BIO|Earnings per share increase in current year NNNN|SHC - Earnings per share growth in current year|Earnings per share growth rate in current year QuidelOrtho Inc.|OPKO Health, Inc. (OPK) - Earnings per share growth in current year|Earnings per share trend in current year CDNA (CareDx)|MRVI (Maravai LifeSciences Holdings, Inc.) - Earnings growth in current year|FLGT: Earnings per share increase in current year|Earnings growth in current year LAB|Earnings growth in current year Cytek Corp (CTKB)|Earnings per share growth in current year OraSure Technologies OSUR|Expected net earnings per share growth this year Exagen Inc (XGN)|MDxHealth - Earnings growth in current year|Earnings per share growth rate in current year Lucid Diagnostics, Inc.|PRE (prenetics.com) - Net earnings per share growth this year|Insight Molecular Diagnostics Inc - Earnings per share increase in current year|Earnings per share growth in current year Trinity Biotech PLC|Earnings per share growth in current year AIMD|Earnings growth in current year CODX|Earnings growth in current year Heart Test Laboratories, Inc. (HSCS)|Earnings growth in current year BMRA (Biomerica, Inc)|Cardio Diagnostics Holdings Inc. - Earnings per share growth in current year|ONCO - Earnings per share growth in current year|Expected net earnings per share growth this year viraxbiolabs.com VRAX|BJDX (Bluejay Diagnostics, Inc.) - Net earnings per share growth this year|Aspira Women's Health, Inc. - Earnings per share increase in current year|AXDX (Accelerate Diagnostics, Inc) - Earnings growth in current year|CENTOGENE N.V. (CNTG) - Expected net earnings per share growth this year|Earnings per share growth in current year Enzo Biochem, Inc. (ENZ)|fresh2.co - Earnings per share growth this year|Earnings growth in current year GENE (Genetic Technologies Limited)|ME - Net earnings per share growth this year|PMD: Net earnings per share growth this year